327 event(s) found
Webinaire SFjRO - Avril 2026 : Radiothérapie des cancers ORL
In French: "Ne manquez pas le premier épisode de cette nouvelle saison des Webinaires SFjRO ! 🎓 Préparez-vous avec des cas cliniques pratiques à compléter avant le webinaire pour une mise en situation concrète : https://lnkd.in/epBcxhJe 👉 Radiothérapie des cancers ORL 🎙️ Animé par le Pr. Florence Huguet et le Dr. Cécile Evin de l’Hôpital Tenon - AP-HP, Assistance Publique - Hôpitaux de Paris 📅 Lundi 20 avril 2026 ⏰ 19h30 🖥️ En visio - lien de connexion diffusé le jour J Au programme : Mise au point théorique et pratique sur la prise en charge en radiothérapie des cancers ORL. Une occasion privilégiée d’actualiser nos connaissances et d’échanger autours de cette localisation complexe."
Oncostream webinar: Cancers de mauvais pronostic féminins : A quel moment faire un séquençage génomique, pour qui, pourquoi ?
In French: "PROGRAMME : 18:00 Introduction (Réseau FEM-NET et objectifs) Isabelle Ray-Coquard 18:05 Les différents types de séquençages (petit et moyen panels, séquençage complet) Sophie Cotteret 18:15 Constats de terrain par les associations de patientes Claude Coutier & Coralie Marjollet 18:30 Quels sont les apports réels d’un séquençage, à qui bénéficie-t-il ? Olivier Tredan & Claudia Lefeuvre-Plesse 18:40 PFMG 2025 : Objectifs, apports, difficultés et avenir Frédérique Nowak 18:55 Table ronde : Quel est le positionnement de FEM-NET et quelle organisation concrète pour mettre en place cet accès équitable au séquençage ? Thomas Bachelot, Sophie Cotteret, Claude Coutier, Véronique Dieras, Claudia Lefeuvre-Plesse, Coralie Marjollet & Olivier Tredan 19:20 Synthèse du positionnement de FEM-NET Thomas Bachelot"
PSCC Petit déjeuner de l'écosystème - Introducing MIPP: The Modelling, ImmunoProfiling and Pharmacology Platform for Translational Innovation
Don't miss the next Ecosystem Breakfast on the topic: Introducing MIPP: The Modelling, ImmunoProfiling and Pharmacology Platform for Translational Innovation. Featuring Anna Martirosyan, MIPP platform (Modelling, ImmunoProfiling and Pharmacology Platform), Hôpitaux Universitaires de Marseille
Innovations in Translational Models: Replacing In Vivo Models With Complex Cellular Systems
More information coming soon…
Lung Cancer Europe Conference 2026
The Lung Cancer Europe 2026 Conference will bring member organisations together in Vienna for three days of learning, connection, and shared priorities. Designed for Lung Cancer Europe members, the conference focuses on practical exchange, collaboration, and strengthening lung cancer advocacy across Europe.
11th Translational Research Conference: Myeloproliferative Neoplasms
ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks. New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.
Location-Specific T-cell Inhibitory Molecules (LoSTIMs) for targeted immunosuppression
Welcome to the Transdisciplinary Immunology Journal Club (TIJC) — your global hub for cutting-edge immunology, cross-disciplinary insights, and career development. TIJC unites physicians, researchers, and students worldwide to explore breakthroughs in immunology, oncology, autoimmunity, and translational medicine. Speaker: James Torchia (Dana-Farber Cancer Institute)
Jeudi du PSCC #19 : In vivo CAR
We are pleased to welcome three outstanding speakers bringing complementary perspectives from research, industry and investment: · Silvia Menegatti, Head of R&D, CellAction / Institut Curie · Christopher Borges, Head of Non-Viral Gene Therapy and Genome Engineering, Sanofi · Sofia Arnal, AdBio partners Together, they will explore the opportunities and challenges shaping in vivo CAR approaches, from scientific innovation and translational development to industrial and investment perspectives.
Pancreatic Cancer Europe 10th Anniversary
We are proud to mark a significant milestone - 10 years of PCE with two impactful events taking place in Valletta, Malta this April: 27 April: Masterclass for Healthcare Professionals Bringing together leading European experts, this masterclass will focus on strengthening a holistic approach to pancreatic cancer care. Participants will gain valuable insights, share best practices, and explore practical strategies to improve patient outcomes and quality of life. 28 April: Public Awareness-Raising Event A dedicated space to raise awareness, highlight the latest scientific advances, and amplify the voices of patients and caregivers. This event will also showcase national and European policy developments and recognise the vital role of advocacy in driving change. More info coming soon...
International Prostate Cancer Symposium (IPCS)
The International Prostate Cancer Symposium (IPCS) is a specialized event that takes place in the days leading up to the Advanced Prostate Cancer Consensus Conference (APCCC). It serves as a focused meeting point where experts, researchers, clinical specialists, and industry representatives gather to delve deeper into specific topics related to next-generation treatment modalities poised to transform prostate cancer care and shape future consensus treatment guidelines. With participants from major academic centers and pharmaceutical companies, IPCS serves as a dynamic platform for cross-sector dialogue, knowledge exchange, and strategic networking. Designed to foster new collaborations and accelerate translational impact, IPCS is a unique opportunity to connect with global thought leaders shaping the future of prostate cancer research and treatment. AACR is pleased to support the IPCS, and the opening lecture from AACR Past President Charles L. Sawyers, MD, FAACR.
2026 ASPHO Conference
The leading conference for pediatric hematology/oncology subspecialists awaits you next spring at the 2026 ASPHO Conference! Don't miss the premier conference for subspecialty education, networking, and inspiration at the 2026 ASPHO Conference in Minneapolis, MN, April 29-May 2, 2026.
Oncostream webinar: Quand une situation fréquente et complexe devient un enjeu majeur dans la prise en charge du cancer du sein
In French: "PROGRAMME : · Introduction Louis Larrouquère · Quelle est la vision des patientes face aux métastases cérébrales ? Claude Coutier et Louis Larrouquère · Comment les diagnostiquer et les suivre ? Claude Coutier et Louis Larrouquère · Y a-t-il une place pour le dépistage ? Claude Coutier et Louis Larrouquère · Quels sont les traitements disponibles aujourd'hui et comment sont-ils perçus par les patientes ? Claude Coutier et Louis Larrouquère · Débat et discussion"
2nd EHA-SWG Scientific Meeting on MDS/MPN/AML : Commonalities and Differences of Myeloid Neoplasms
This comprehensive 2.5-day event builds on the success of the inaugural EHA-SWG Scientific Meeting on MDS/MPN/AML, held in November 2023, which has proven to be a pivotal platform for identifying key similarities and differences between Myelodysplastic Neoplasms (MDS), Myeloproliferative Neoplasms (MPN), and Acute Myeloid Leukemia (AML). It aims to delve deeply into basic and translational science, while also exploring the most recent advances in science and clinical care for these diseases. Representing a unique opportunity to convene experts in these three distinct yet overlapping areas, the event is targeted at various levels, from experienced hematologists to junior trainees.
Highlights of ASH in Latin America
Highlights of ASH in Latin America brings global hematology leaders together for two days in Bogotá, Colombia. Discuss the most influential and novel research from the latest ASH Annual Meeting, spanning a wide range of topics.
Rocky Mountain Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
Oncostream webinar: Changement de pratique dans le traitement adjuvant du cancer de l’endomètre en 2026
In French: "PROGRAMME : 18:00 En quoi la nouvelle classification proposée dans les recommandations de l’ESGO peut impacter nos pratiques ? Alexandra Leary 18:25 Controverse sur la place de la radiothérapie Cyrus Chargari 18:50 Les traitements médicaux adjuvants : quelles évolutions ? Florence Joly 19:15 Débat/discussion – Réponses aux questions"
33rd Annual TRI-CON: Precision Medicine Innovation
Join us for an exclusive gathering of senior-level investors, pharma executives, entrepreneurs, research thought leaders, and innovators at the 33rd Annual TRI-CON. Connect with investors and partners at intimate networking sessions; gain strategic insights on funding activities, business development, and innovation strategies in diagnostics, precision medicine, and AI from industry-led panels; and hear candid perspectives and business recommendations from key opinion leaders during dynamic fireside chats.
Myeloma Week 2026 - Understanding Myeloma: From Diagnosis to Treatment Foundations
In this webcast, we break down what myeloma is, how it develops, and the key signs and symptoms that often lead to diagnosis. We’ll explain the current understanding of risk factors, how the disease behaves in the body, and the tools clinicians use to monitor and assess its progression. Participants will also learn about today’s treatment landscape, including first-line therapies and emerging drug classes that are shaping the future of myeloma care.
ESMO Breast Cancer 2026
Join the global breast cancer community in Berlin, Germany, from 6 to 8 May 2026 or online for a specialised event dedicated to advancing the care and treatment of patients worldwide. This international congress will bring together leading experts, researchers, and clinicians to examine the latest breakthroughs in breast cancer across the entire care continuum—from early detection to treatment innovations and long-term survivorship. Explore the most up-to-date science in breast cancer diagnosis and treatment strategies, collaborate with global experts to share real-world experiences and help us build the future of breast cancer care.
Post AACR Debriefing
Join us for a two-hour debriefing session following the AACR Annual Meeting, co-organised by PSCC and Prism Institute. The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. Teams from Prism will highlight some the latest breakthroughs in cancer research that were presented during the meeting : • "Highlights in Cancer Prevention, Early Detection, and Interception", Bruno Achutti-Duso, Gustave Roussy • "Next-Generation Biomarker Discovery Tools, with a Focus on Antibody-Drug Conjugates (ADCs)", Cyril Roussel-Simonin, Gustave Roussy • "Advances in Liquid Biopsy to Guide Precision Medicine", Antoine Italiano, Gustave Roussy • "New Targets in Oncology", Joana Ribero, Gustave Roussy • "Clinical Trials Update on Targeted Therapies", Lisa Derosa, Gustave Roussy • "Immunotherapy in 2026: What’s New, What’s Next?", François-Xavier Danlos, Gustave Roussy
Oncostream webinar: Repousser les limites dans le traitement du cancer de l’ovaire résistant au platine
In French: "PROGRAMME : · Introduction Isabelle Ray-Coquard · Évolution des biomarqueurs dans le cancer de l'ovaire de haut grade : perspectives actuelles et émergentes Guillaume Bataillon · Cancer de l'ovaire platino-résistant ou réfractaire : situation actuelle et approches émergentes Jean-Sébastien Frenel · Un aperçu de l'avenir : essais cliniques clés dans le domaine du cancer de l'ovaire platino-résistant Laurianne Eberst Débat et discussion"
2nd Symposium : AI for Clinical and Translational Medicine
Building on the success of our inaugural event, this year’s symposium brings together an exceptional lineup of international speakers, cutting‑edge research presentations, and engaging interactive sessions. Throughout the day, we will spotlight the latest breakthroughs in AI and their transformative impact on clinical and translational medicine. From predictive analytics and personalized treatment strategies to AI‑powered diagnostics and decision‑support systems, the program will showcase how data‑driven innovations are reshaping the future of healthcare.
Advances in Cell-based Screening
The pharmaceutical industry is poised for a paradigm shift: moving away from animal models prior to human trials. This conference unites leaders from pharma, academia, and the exhibitor ecosystem to address the critical question: What is needed to engineer the post-animal drug discovery pipeline? Achieving this future requires fundamental changes – testing compounds earlier in more relevant cells, at significantly larger scales, to generate the comprehensive foundational data necessary to reduce animal dependency.
Webinar: Characterisation of immune response in tumor‑draining lymph nodes of NSCLC patients treated with neoadjuvant chemo‑immunotherapy
Join this open webinar to learn about how neoadjuvant chemo‑immunotherapy reshapes the immune landscape of tumor‑draining lymph nodes and informs patient stratification. Speaker: Dr. Francesca Lucibello, MD, PhD (Medical oncologist, Institut Curie). Dr. Lucibello is an immunologist at the European Center for Immunotherapy Research and Excellence (CIRCE), where her research focuses on tumor–immune interactions, immune microenvironment modulation, and translational immuno‑oncology. Moderators: Samuel Bitoun & François‑Xavier Danlos Clinicians, scientists, residents, PhD students and immunology enthusiasts are all welcome!